Cardiovascular side-effects of common antibiotics

Francesco Amati, Marta Di Pasquale, Marcos I. Restrepo, Judith Marin-Corral, Stefano Aliberti, Francesco Blasi

Source: Eur Respir Monogr 2020; 88: 264-278
Disease area: Respiratory infections

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Francesco Amati, Marta Di Pasquale, Marcos I. Restrepo, Judith Marin-Corral, Stefano Aliberti, Francesco Blasi. Cardiovascular side-effects of common antibiotics. Eur Respir Monogr 2020; 88: 264-278

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Cardiovascular adverse effects during itraconazole therapy
Source: Eur Respir J 2008; 32: 240
Year: 2008

Cardiovascular complications and comorbidities in CAP
Source: Eur Respir Monogr 2014; 63: 256-254
Year: 2014

Cardiovascular events related to the use of varenicline
Source: Annual Congress 2012 - Tobacco cessation
Year: 2012

Cardiovascular diseases and COVID-19
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

Severe adverse effects of antitubercular drugs and patient management
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

Cardiovascular complications of mild OSA
Source: ERS Conference
Year: 2015

Cardiovascular complications of mild OSA
Source: International Congress 2017 – Sleep and Breathing
Year: 2017

Cardiovascular complications in mild OSA
Source: Sleep and Breathing Conference 2017
Year: 2017

Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016

Cardiovascular complications and norfenfluramine exposure with benfluorex use
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008

Active monitoring of adverse drug reactions to the use of beta-lactam antibiotics in the treatment of community-acquired pneumonia
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020

Cardiovascular patients
Source: Eur Respir Monogr 2021; 90: 208-228
Year: 2021

Antibiotics therapy against airway’s infections during pregnancy and related problems
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013

Respiratory adverse effects in oncology nurses exposed to antineplastic drugs
Source: International Congress 2015 – Occupational and environmental cohort investigations and population studies
Year: 2015

Adverse effects of anti-tuberculosis drugs in hemodialysis patients
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019

Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016

Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016

Adverse anti-tuberculosis drug events and their management
Source: Eur Respir Monogr 2018; 82: 205-227
Year: 2018

Management of adverse drug events in TB therapy
Source: Eur Respir Mon 2012; 58: 167-193
Year: 2012